A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II study

PURPOSE: FOLFOX is a standard combination chemotherapy regimen for metastatic colorectal cancer (CRC). 5-Fluorouracil (5-FU) is infused continuously through a pump for 46 h; therefore, replacement of infused 5-FU with oral S-1 would be more convenient for patients. We investigated the efficacy and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimomura, Manabu, Shinozaki, Katsunori, Hinoi, Takao, Yoshimitsu, Masanori, Kurayoshi, Manabu, Sumitani, Daisuke, Ishizaki, Yasuyo, Oshiro, Takafumi, Kodama, Shinya, Shimizu, Yosuke, Arita, Michinori, Tokunaga, Masakazu, Yoshida, Makoto, Tanaka, Junko, Ohdan, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069218/
https://www.ncbi.nlm.nih.gov/pubmed/27803845
http://dx.doi.org/10.1186/s40064-016-3491-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069218/
https://www.ncbi.nlm.nih.gov/pubmed/27803845
http://dx.doi.org/10.1186/s40064-016-3491-8

Ejemplares similares